TRMT112 Drives a Tumor Growth and Metastasis-Promoting Program in Triple-Negative Breast Cancer

Functional assays demonstrated that tRNA methyltransferase activator subunit 11-2 (TRMT112) knockdown in TNBC cells significantly reduces proliferation, migration, invasion, and metastatic potential, whereas its overexpression enhanced these tumorigenic properties.